Andrew Booth's Insider Trades & SAST Disclosures

Andrew Booth's most recent trade in AbCellera Biologics Inc was a trade of 1,352,054 Share option (right to buy) done . Disclosure was reported to the exchange on Jan. 1, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Jan 2025 1,352,054 7,942,951 - - Share option (right to buy)
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 14 Jan 2024 770,416 6,590,897 - - Share option (right to buy)
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 6.85 per share. 26 May 2023 14,500 153,000 - 6.9 99,325 Common Shares
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 20 Dec 2022 50,000 5,820,481 - - Share option (right to buy)
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Gift of securities by or to the insider at price $ 0.00 per share. 20 Dec 2022 50,000 138,500 - 0 Common shares
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.19 per share. 20 Dec 2022 50,000 188,500 - 0.2 9,500 Common Shares
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Dec 2022 485,661 5,870,481 - - Share Options (right to buy)
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 5.79 per share. 12 May 2022 85,000 138,500 - 5.8 492,150 Common Shares
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 07 Dec 2021 406,020 5,884,820 - - Share Option (right to buy)
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 14.74 per share. 11 Nov 2021 53,500 53,500 - 14.7 788,590 Common Shares
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Purchase of securities on an exchange or from another person at price $ 14.61 per share. 11 Nov 2021 14,000 130,959 - 14.6 204,540 Common Shares
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Sale of securities on an exchange or to another person at price $ 25.50 per share. 09 Jun 2021 1,200,000 0 - 25.5 30,600,000 Common Shares
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.32 per share. 07 Jun 2021 600,000 1,200,000 - 0.3 192,000 Common Shares
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2021 600,000 4,950,000 - - Share Option (right to buy)
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. 07 Jun 2021 600,000 300,000 - - Share Option (right to buy)
AbCellera Biologics Inc
Andrew Booth Chief Financial Officer Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.19 per share. 07 Jun 2021 600,000 600,000 - 0.2 114,000 Common Shares
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades